Featured Image

August 6, 2024

Profound Research and Cardiology and Vascular Associates (CAVA) Announce Clinical Research Partnership and Center of Excellence in Detroit 

Profound Research (Profound), a leading clinical site network, and Cardiology and Vascular Associates (CAVA), a prominent cardiology and vascular medicine group, have announced a clinical research partnership and the formation of a Clinical Research Center of Excellence in the Detroit metropolitan area.

The Center of Excellence will initially reside in Bloomfield Hills near the Detroit metro area, focusing on clinical trials and medical innovation in cardiology. This partnership will provide Profound with access to CAVA’s extensive network of physicians, while CAVA will benefit from Profound’s expertise in patient recruitment, trial execution, and data management.

This collaboration aligns seamlessly with Profound's mission of bringing patients access to tomorrow's treatments today. By leveraging the combined strengths of both organizations, patients will have the opportunity to participate in cutting-edge clinical trials, gaining early access to innovative therapies that can significantly improve their health outcomes.

Direct benefits for patients include the introduction of innovative therapies to the Detroit community, advancing the development of new treatments and cures, and more. By working together, Profound and CAVA are committed to providing patients with opportunities to participate in clinical trials that can improve their treatments and overall health outcomes. This partnership is a testament to Profound's core values of compassion, efficiency, progress, and integrity, ensuring that patients receive the best possible care through advanced medical research and innovation.

Patient Benefits: 

  • Access to Cutting-Edge Therapies and Treatments: Patients will have early access to the latest advancements in cardiology care, reducing wait times for new therapies and providing hope for those with limited options. 
  • Participation in Advanced Clinical Trials: Opportunities to be part of research that can lead to breakthrough treatments and personalized therapy plans based on the latest clinical data. 
  • Improved Health Outcomes: Through innovative care options that target specific cardiology-related issues, ensuring a more holistic approach to patient health. 
  • Enhanced Support: From a network of leading cardiologists and researchers dedicated to comprehensive patient care and coordinated management. 
  • Convenient Access: To state-of-the-art medical facilities in their community, minimizing travel burdens and associated stress. 
  • Collaboration with Your Own Cardiologist: Patients can participate in clinical trials while continuing care with their trusted cardiologist, ensuring continuity and personalized treatment. 

Profound Research and CAVA are currently partnering on cardiology trials with more launching in the coming months.

About Profound Research 

Profound Research is an integrated clinical research network composed of trial sites embedded into independent physician practices.  Profound’s mission is to expand access to clinical research for patients in the community and give community physicians more therapeutic options.  Profound Research has locations across Southern California and in the Detroit metropolitan area and is expanding nationwide. The company has a team of experienced and dedicated research professionals who are committed to providing the highest quality clinical research support to physicians and their patients. 

About Cardiology and Vascular Associates 

Cardiology and Vascular Associates (CAVA), established in 2000, is one of Michigan’s premier cardiology practices. With 11 board-certified cardiologists and 8 mid-level providers, CAVA offers comprehensive cardiac and vascular care across 5 office locations and multiple area hospitals. Our diagnostic centers, accredited by the IAC, feature advanced equipment and certified technicians. CAVA's services include diagnostic and interventional cardiology, cardiac consultation, arrhythmia management, and endovascular procedures. Our physicians, trained at top institutions worldwide, hold leadership roles in prestigious hospitals and actively participate in cutting-edge research. 

Featured Image

January 31, 2024

Enhancing Cardiovascular Research: Profound’s Collaborative Approach with MHP CAVA

Clinical research plays a crucial role in advancing medical knowledge, with sponsors and contract research organizations frequently facing the challenges posed by the intricacies of cardiovascular studies. One prevalent challenge is the limited availability of US-based sites, prompting sponsors to seek new, community-based alternatives. Profound Research empathizes with these challenges and has developed a thoughtful approach to simplify a comprehensive range of clinical studies, including cardiovascular.

Understanding Sponsor Challenges:

Sponsors navigating the intricate landscape of cardiovascular research often encounter hurdles due to a restricted US-based site footprint. This saturation poses challenges in conducting studies efficiently and reaching diverse patient populations. Profound Research acknowledges this dilemma and has tailored its model to provide sponsors with a solution that overcomes typical challenges and aligns with their goals.

The Key Solutions: Community-based Partnerships and Central Support

To solve these challenges in the cardiovascular space, Profound Research, whose network also includes MHP TriaAtria and Southern California Heart Specialists, has formed a partnership with Michigan Healthcare Professionals Cardiology and Vascular Associates (MHP CAVA). Situated at 42557 Woodward Avenue, Suite 200, Bloomfield Hills, MI 48304, MHP CAVA serves a diverse range of populations just 30 minutes outside of Detroit.

One: Leadership at MHP CAVA

At the forefront of this collaborative effort are two highly experienced interventional cardiologists: Abdul R. Halabi, M.D., FACC and Kirit Patel, M.D., FACC. With a collective experience exceeding fifty years, these providers have dedicated themselves to advancing cardiovascular medicine and have played pivotal roles as principal or sub-investigators in over seventy research studies. Their commitment to patient well-being and innovation aligns seamlessly with Profound's mission of actively connecting patients to advanced therapeutic options in their own communities.

Two: Profound's Comprehensive, Centralized Support

Beyond establishing strategic relationships and connecting sponsors with community-based providers, Profound Research offers central support to sponsors, covering crucial aspects such as technology, feasibility, budget and contract, regulatory and startup processes, as well as quality control. This centralized support ensures that sponsors can concentrate on the scientific aspects of their studies while Profound handles the logistical and administrative challenges, resulting in expedited progress and truncated timelines from start-up on through the fruition of clinical advancements. To learn more about Profound's approach to centralized support, click here.

Taking Action: How Sponsors Can Benefit

To get started, Profound Research invites sponsors to include any one of our four cardiovascular research sites in ongoing and planned feasibility processes for cardiovascular studies. By doing so, sponsors will access a largely untapped patient population along with the expertise of our highly skilled team at MHP CAVA. We look forward to discussing with innovators in the cardiovascular space how Profound’s cardiovascular sites can tailor support to specific research needs.

Conclusion

In cardiovascular research, Profound Research emerges as a preferred collaborative partner, offering thoughtful solutions to sponsors seeking efficient and impactful studies. The partnership with MHP CAVA, coupled with Profound's comprehensive support, creates an inviting opportunity for sponsors to advance their research goals seamlessly. By engaging with Profound's feasibility team at feasibility@profoundresearch.io, sponsors can take the first step toward transforming their cardiovascular research initiatives.

Profound Research LLC, 1213 5th Avenue North, Nashville, TN 37208